Software to predict the right dose for vancomycin in a clinical environment-A commentary on: Personalised dosing of vancomycin: A prospective and retrospective comparative quasi-experimental study by Luqman Vali et al.

Dijkstra, Jacob A; Veldkamp, Agnes I; Sieswerda, Elske; van Agtmael, Michiel

Dijkstra, Jacob A; Veldkamp, Agnes I; Sieswerda, Elske; van Agtmael, Michiel.

Afiliação

Dijkstra JA; Department of Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Veldkamp AI; Department of Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Sieswerda E; Department of Medical Microbiology and Infection Control, Amsterdam University Medical Center, Amsterdam, The Netherlands.
van Agtmael M; Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Br J Clin Pharmacol ; 87(9): 3481-3482, 2021 09.

Article em En | MEDLINE | ID: mdl-33638868

Assuntos

Antibacterianos; Vancomicina; Antibacterianos/efeitos adversos; Humanos; Estudos Prospectivos; Estudos Retrospectivos; Software; Vancomicina/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vancomicina / Antibacterianos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google